Cell Therapy Technology
Total Trials
17
As Lead Sponsor
As Collaborator
0
Total Enrollment
1,329
NCT00012064
Vaccine Therapy in Treating Patients With Stage IV or Recurrent Melanoma
Phase: Phase 1/2
Role: Lead Sponsor
Start: Jul 31, 2000
Completion: Apr 30, 2011
NCT00014131
Vaccine Therapy in Treating Patients With Kidney Cancer
Phase: Phase 1
Start: Nov 30, 2001
Completion: Dec 31, 2009
NCT00300053
ACT34-CMI -- Adult Autologous CD34+ Cells
Phase: Phase 2
Start: Apr 30, 2006
Completion: Mar 31, 2009
NCT00545610
ACT34-CMI -- Adult Autologous CD34+ Stem Cells (Follow-Up Study)
Phase: N/A
Start: Oct 31, 2007
Completion: Jun 30, 2010
NCT00814593
Lymphokine-Activated Killer Cells or Gliadel Wafer in Treating Patients With Newly Diagnosed Glioblastoma Multiforme That Can Be Removed by Surgery
Start: Nov 30, 2008
Completion: Sep 30, 2011
NCT01495364
NBS10 (Also Known as AMR-001) Versus Placebo Post ST Segment Elevation Myocardial Infarction
Start: Dec 31, 2011
Completion: Apr 30, 2016
NCT01508910
Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina
Phase: Phase 3
Start: Apr 30, 2012
Completion: Nov 30, 2015
NCT01875653
Autologous Dendritic Cell-Tumor Cell Immunotherapy for Metastatic Melanoma
Start: Oct 31, 2014
Completion: Jan 31, 2016
NCT02691247
Safety and Efficacy of CLBS03 in Adolescents With Recent Onset Type 1 Diabetes (The Sanford Project T-Rex Study)
Start: Feb 29, 2016
Completion: Jan 31, 2020
NCT02501018
Study to Assess the Efficacy and Safety of CLBS12 in Patients with Critical Limb Ischemia (CLI)
Start: Nov 1, 2017
Completion: May 19, 2022
NCT03508609
Safety and Potential Bioactivity of CLBS16 in Patients With Coronary Microvascular Dysfunction and Without Obstructive Coronary Artery Disease
Start: Apr 19, 2018
Completion: May 5, 2020
NCT03517176
CEND-1 in Combination With Nabpaclitaxel and Gemcitabine in Metastatic Pancreatic Cancer
Start: Jul 31, 2018
Completion: Jun 19, 2020
NCT04522817
CLBS119 for Repair of COVID-19 Induced Pulmonary Damage
Start: Oct 5, 2020
Completion: May 31, 2021
NCT04614467
A Placebo-Controlled Trial of CLBS16 in Subjects With Coronary Microvascular Dysfunction
Start: Oct 29, 2020
Completion: Sep 28, 2022
NCT04990427
CLBS201 in Patients with Chronic Kidney Disease (CKD) and Type 2 Diabetes Mellitus (T2DM)
Start: Jan 10, 2022
Completion: Jan 26, 2023
NCT05712356
A Study of LSTA1 When Added to Standard of Care Versus Standard of Care Alone in Patients With Advanced Solid Tumors
Start: Aug 24, 2023
Completion: Mar 31, 2030
NCT06592664
Certepetide Phase 1b/2a Continuous Infusion Trial in mPDAC
Start: Jan 31, 2030
Completion: Jan 31, 2040
Loading map...